Related Experiment Video
Updated: Aug 10, 2026
06:04
Murine Dermal Fibroblast Isolation by FACS
Published on: January 7, 2016
Fibroblasts as target cells for DEB gene therapy
1Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.
The Journal of Investigative Dermatology
|March 17, 2006
Summary
Dystrophic epidermolysis bullosa (DEB) therapies focus on correcting mutations in the type VII collagen (C7) gene. Dermal fibroblasts show promise for delivering C7 in gene therapy approaches for DEB.
Area of Science:
- Biotechnology
- Genetics
- Dermatology
Background:
- Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder caused by mutations in the type VII collagen (C7) gene.
- Current research explores therapeutic strategies to address C7 deficiency in DEB patients.
Discussion:
- Investigates the potential of ex vivo gene therapy and intradermal injections for DEB treatment.
- Compares the efficacy of delivering C7 via gene-corrected fibroblasts, lentiviral vectors, or recombinant C7.
- Highlights the advantages of dermal fibroblasts over epidermal keratinocytes for C7 delivery in DEB.
Key Insights:
- Dermal fibroblasts offer a viable cellular vehicle for C7 gene therapy in DEB.
- Molecular engineering strategies are crucial for effective C7 protein replacement.
- The study provides a comparative analysis of different therapeutic delivery systems for DEB.
Outlook:
- Further research into optimizing fibroblast-mediated gene delivery for DEB.
- Development of novel recombinant C7 formulations for enhanced therapeutic outcomes.
- Potential for improved quality of life for DEB patients through advanced gene therapies.
Related Concept Videos
01:09Introduction to Fibroblasts
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...